132 related articles for article (PubMed ID: 5695780)
1. Evaluation of the relationship between long-acting thyroid stimulator, clinical and biological thyrotoxicosis and exophthalmos.
Bonnyns M; Demeester-Mirkine N; Calay R; Bastenie PA
Acta Endocrinol (Copenh); 1968 Aug; 58(4):581-92. PubMed ID: 5695780
[No Abstract] [Full Text] [Related]
2. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
Friis T
Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
[No Abstract] [Full Text] [Related]
3. CLINICAL STUDIES ON THE LONG-ACTING THYROID STIMULATOR.
NOGUCHI A; KURIHARA H; SATO S
J Clin Endocrinol Metab; 1964 Feb; 24():160-5. PubMed ID: 14123839
[No Abstract] [Full Text] [Related]
4. The long-acting thyroid stimulator and the result of I 131 treatment for thyrotoxicosis.
Martin FI; Larkins RG; Alford FP; Andrews JT; Greenberg PB; Melick RA; Penington JS
Aust N Z J Med; 1972 May; 2(2):168-72. PubMed ID: 4116447
[No Abstract] [Full Text] [Related]
5. [Comparative values of protein-bound iodine, the in vitro thyroxine-binding protein capacity and blood cholesterol level in some diseases of the thyroid gland].
Soumar J; Bednár J; Strasek J
Endokrinologie; 1967; 52(3):216-27. PubMed ID: 4172943
[No Abstract] [Full Text] [Related]
6. An improved bio-assay for the determination of long-acting thyroid stimulator (LATS).
Ason EK; Hetzel BS; Good BF; Stenhouse NS
J Clin Endocrinol Metab; 1967 Nov; 27(11):1529-39. PubMed ID: 6075584
[No Abstract] [Full Text] [Related]
7. [Long-acting thyroid stimulator (LATS) in thyroid pathology].
Winand R
Rev Med Liege; 1970 Aug; 25(15):478-82. PubMed ID: 5468466
[No Abstract] [Full Text] [Related]
8. Radioactive iodine therapy for progressive malignant exophthalmos.
Bauer FK; Catz B
Acta Endocrinol (Copenh); 1966 Jan; 51(1):15-22. PubMed ID: 5951873
[No Abstract] [Full Text] [Related]
9. Radioactive iodine therapy for progressive malignant exophthalmos.
Bauer FK; Catz B
Acta Endocrinol (Copenh); 1966 Jan; 51(1):14-22. PubMed ID: 5951904
[No Abstract] [Full Text] [Related]
10. Thyrotoxicosis.
Lancet; 1967 Dec; 2(7527):1186-7. PubMed ID: 4168385
[No Abstract] [Full Text] [Related]
11. Thyroid suppression and the long-acting thyroid stimulator following radioactive iodine therapy for thyrotoxicosis.
Alford FP; Larkins RG; Martin FI
Aust N Z J Med; 1971 Nov; 1(4):339-45. PubMed ID: 5292990
[No Abstract] [Full Text] [Related]
12. The nucleic acid content of lymphocytes in thyrotoxicosis.
Smith JF; Glen AC; Greig WR
Clin Exp Immunol; 1971 Jun; 8(6):911-6. PubMed ID: 5104635
[TBL] [Abstract][Full Text] [Related]
13. [Action of 1-triiodothyronine on protein-bound iodine in the blood (PBI 127) of patients suffering from hyperthyroidism with diffuse thyroid hyperplasia].
Mahaux J; Levin S; Nagel M
Ann Endocrinol (Paris); 1967; 28(2):214-9. PubMed ID: 4167430
[No Abstract] [Full Text] [Related]
14. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
15. [Relation between the exophthalmos producing factor (EPF) and thyroid antibodies].
Kreysing G; Schemmel K; Weisbecker L; Uthgenannt H; Müller W; Kirmse L
Schweiz Med Wochenschr; 1968 Jun; 98(23):852-4. PubMed ID: 5666557
[No Abstract] [Full Text] [Related]
16. [Clinical studies of long-acting thyroid stimulator].
Eguchi Y
Nihon Naibunpi Gakkai Zasshi; 1970 Nov; 46(8):939-52. PubMed ID: 4099204
[No Abstract] [Full Text] [Related]
17. Dissociation between thyroid injury and formation of long-acting thyroid stimulator in thyrotoxicosis.
Burke G
Ann Intern Med; 1967 Aug; 67(2):349-55. PubMed ID: 6036394
[No Abstract] [Full Text] [Related]
18. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
McKenzie JM; McCullagh EP
J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
[No Abstract] [Full Text] [Related]
19. Ophthalmopathy without hyperthyroidism in patients with histologic Hashimoto's thyroiditis.
Wyse EP; McConahey WM; Woolner LB; Scholz DA; Kearns TP
J Clin Endocrinol Metab; 1968 Nov; 28(11):1623-9. PubMed ID: 5754841
[No Abstract] [Full Text] [Related]
20. [The long-acting thyroid stimulator (LATS) in untreated and I-131 treated hyperthyreoses, following total thyroidectomy, as well as its relation to thyroid antibodies].
Ziemke A; Weisbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W
Klin Wochenschr; 1968 Oct; 46(19):1025-7. PubMed ID: 5727481
[No Abstract] [Full Text] [Related]
[Next] [New Search]
